Structuring and strengthening an ecosystem for biotherapies and bioproduction

Note rapide Economy, #47

22 September 2021ContactValérie Constanty

Biotherapies comprise treatments derived from biological entities such as bacteria, viruses or animal cells that are genetically modified then cultured in mass in bioreactors. They, and their industrial production, called bioproduction, are key sectors for the future of the pharmaceutical industry. Biotherapies play a role in the technological, economic and healthcare independence of France. Paris Region is a major actor in certain biotherapies, particularly gene and cell therapies. However, the region needs to strengthen its capacities in bioproduction and ensure this latter's future by training tomorrow's talents.

 

This study is linked to the following theme :
Economy


Download the Quick Note

Related studies

Paris Region: at the cutting edge of biotechnologies and gene & cell therapies

Note rapide Economy, #33

Paris Region is a hub of scientific excellence and furthermore home to numerous competencies in the strategic sector of next-generation biological medicines. Public-private partnerships for biotherapy R&D benefit greatly from the presence of large biopharmaceutical groups in ...

March 2020 Valérie Constanty, Delphine Brajon

The healthcare industry in the Paris Region: a powerful sector facing strategic challenges

Note rapide Economy, #30

Healthcare players in the Paris Region benefit from a very favourable environment, featuring: internationally recognised scientific research; state-of-the-art hospitals; business incubators and institutional support. The number of R&D personnel has doubled in key sectors ...

November 2019 Valérie Constanty, Delphine Brajon